Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cnossen

Showing results (231-240 of 442) with videos related to

Pageof 45
Sort By:
BMC Medical Research Methodology|March 7, 2025
The use of race and ethnicity in sickle cell disease researchAida S Kidane Gebremeskel, Minke A Rab, Erik D van Werkhoven, et al.
BMJ Open|June 27, 2023
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia AAnouk Donners, Konrad van der Zwet, Antoine C G Egberts, et al.
Critical Care Medicine|February 8, 2017
Causes and Consequences of Treatment Variation in Moderate and Severe Traumatic Brain Injury: A Multicenter StudyMaryse C Cnossen, Suzanne Polinder, Teuntje M Andriessen, et al.
Injury|August 30, 2018
Validation and reliability of the Abbreviated World Health Organization Quality of Life Instrument (WHOQOL-BREF) in the hospitalized trauma populationN Kruithof, J A Haagsma, M Karabatzakis, et al.
Journal of the American Chemical Society|July 6, 2017
Electronic Delocalization in the Radical Cations of Porphyrin Oligomer Molecular WiresMartin D Peeks, Claudia E Tait, Patrik Neuhaus, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 28, 2014
Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scaleJ Lock, H Raat, N Duncan, et al.
British Journal of Haematology|March 24, 2020
Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case-control studyAlice S van Velzen, Corien L Eckhardt, Marjolein Peters, et al.
Thrombosis and Haemostasis|February 20, 2018
Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A PatientsLisette M Schütte, Reinier M van Hest, Sara C M Stoof, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic studyJessica M Heijdra, Michael E Cloesmeijer, Nico C B de Jager, et al.
Journal of Contemporary Brachytherapy|May 29, 2024
Post-operative complications following dose adaptation of intra-operative electron beam radiation therapy in locally advanced or recurrent rectal cancerFloor Piqeur, Heike M U Peulen, Jeltsje S Cnossen, et al.
Pageof 45

Showing results (231-240 of 442) with videos related to

Sort By:
Pageof 45
BMC Medical Research Methodology|March 7, 2025
The use of race and ethnicity in sickle cell disease researchAida S Kidane Gebremeskel, Minke A Rab, Erik D van Werkhoven, et al.
BMJ Open|June 27, 2023
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia AAnouk Donners, Konrad van der Zwet, Antoine C G Egberts, et al.
Critical Care Medicine|February 8, 2017
Causes and Consequences of Treatment Variation in Moderate and Severe Traumatic Brain Injury: A Multicenter StudyMaryse C Cnossen, Suzanne Polinder, Teuntje M Andriessen, et al.
Injury|August 30, 2018
Validation and reliability of the Abbreviated World Health Organization Quality of Life Instrument (WHOQOL-BREF) in the hospitalized trauma populationN Kruithof, J A Haagsma, M Karabatzakis, et al.
Journal of the American Chemical Society|July 6, 2017
Electronic Delocalization in the Radical Cations of Porphyrin Oligomer Molecular WiresMartin D Peeks, Claudia E Tait, Patrik Neuhaus, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 28, 2014
Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scaleJ Lock, H Raat, N Duncan, et al.
British Journal of Haematology|March 24, 2020
Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case-control studyAlice S van Velzen, Corien L Eckhardt, Marjolein Peters, et al.
Thrombosis and Haemostasis|February 20, 2018
Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A PatientsLisette M Schütte, Reinier M van Hest, Sara C M Stoof, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic studyJessica M Heijdra, Michael E Cloesmeijer, Nico C B de Jager, et al.
Journal of Contemporary Brachytherapy|May 29, 2024
Post-operative complications following dose adaptation of intra-operative electron beam radiation therapy in locally advanced or recurrent rectal cancerFloor Piqeur, Heike M U Peulen, Jeltsje S Cnossen, et al.
Pageof 45